Antiviral drug resistance: mechanisms and clinical implications - Wikidata - awgldk - TriplyDB

Antiviral drug resistance: mechanisms and clinical implications

Antiviral drug resistance: mechanisms and clinical implications

http://www.wikidata.org/entity/Q28282376

about

Multidrug resistance: an emerging crisis Update on emerging antivirals for the management of herpes simplex virus infections: a patenting perspective.The Role of Eukaryotic and Prokaryotic ABC Transporter Family in Failure of Chemotherapy.Potential of small-molecule fungal metabolites in antiviral chemotherapy.Structure-Activity Relationships of Acyclic Selenopurine Nucleosides as Antiviral Agents.Synthesis of Pyrazine-1,3-thiazine Hybrid Analogues as Antiviral Agent Against HIV-1, Influenza A (H1N1), Enterovirus 71 (EV71), and Coxsackievirus B3 (CVB3).Cetylpyridinium Chloride (CPC) Exhibits Potent, Rapid Activity Against Influenza Viruses in vitro and in vivo Drug-resistance associated mutations in polymerase (p) gene of hepatitis B virus isolated from malaysian HBV carriers.Lamivudine compared with newer antivirals for prophylaxis of hepatitis B core antibody positive livers: a cost-effectiveness analysis.Estimation of the wild-type minimum inhibitory concentration value distribution.Targeting Human-Cytomegalovirus-Infected Cells by Redirecting T Cells Using an Anti-CD3/Anti-Glycoprotein B Bispecific Antibody.Phosphorylation of thymidylate synthase affects slow-binding inhibition by 5-fluoro-dUMP and N(4)-hydroxy-dCMP.In Silico Designed Axl Receptor Blocking Drug Candidates Against Zika Virus Infection.

P2860

Q21284693-7B5E44E9-D42A-4329-9FC2-AF2849B0357F Q35531731-510C0FDB-54D4-4D8A-B3CB-8932E600C7DD Q37576360-D28D3B6F-FB71-4AB9-85F2-A8A57287EE1D Q39453829-25E71DAE-0D7C-4CEF-8A05-82DF6FB177F8 Q40123927-ACD81320-8E21-422A-9F94-83BE54820710 Q40721270-FE7A3246-E9B3-4C45-AC4C-025E1EDA7B17 Q41722887-66E4B48C-AA05-4B97-8791-9B82BEA4DEC1 Q41905382-5291E881-FB04-4144-9754-7BA0B4ABE221 Q42231482-E98342D9-3FEC-4373-92C9-D1D390A0C7DF Q44389963-8F708796-7FE3-4204-9E31-9B96A06B0043 Q47610511-5860123A-81A8-4400-8C2D-91BBAC68C8E4 Q53166301-341B78A8-03F2-4B95-ABE5-8D336C3967AC Q55669574-13F7372A-C3A0-4CC7-B2E0-8DF1CC8BC536

P2860

Antiviral drug resistance: mechanisms and clinical implications

http://www.wikidata.org/entity/Q28282376

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Antiviral drug resistance: mechanisms and clinical implications

@ast

Antiviral drug resistance: mechanisms and clinical implications

@en

Antiviral drug resistance: mechanisms and clinical implications

@nl

type

label

Antiviral drug resistance: mechanisms and clinical implications

@ast

Antiviral drug resistance: mechanisms and clinical implications

@en

Antiviral drug resistance: mechanisms and clinical implications

@nl

prefLabel

Antiviral drug resistance: mechanisms and clinical implications

@ast

Antiviral drug resistance: mechanisms and clinical implications

@en

Antiviral drug resistance: mechanisms and clinical implications

@nl

P1433

Q28282376-63C5B9A9-3358-4093-BC55-BDFD0E2D3194

P1476

Q28282376-4893482F-9AF3-4116-9BB8-41989345C263

P2093

Q28282376-57DE6BE4-94DB-4BF2-87DA-079FCC8BA5A1

Q28282376-9D13515F-E275-401B-871B-62A9FCB8ABFA

P2860

Q28282376-01D4AE3C-1EBC-4A3E-ADA7-B7D4181BAE6B

Q28282376-038A48E2-007E-425E-A912-869F4873D23D

Q28282376-047DC19C-E5F0-4F13-9A83-5B3D0EDDD9CC

Q28282376-04D83C25-6C5F-4CE6-B163-7AFDDCECC80A

Q28282376-0B50E52E-B42F-440F-B9EB-9E7B9723969A

Q28282376-0D3058C7-F9BD-4712-95BC-BDE9F0B0BED8

Q28282376-16B4EA4F-BAF2-4B03-8591-DB78A4500B31

Q28282376-1BB06FB0-1BAF-4793-8E83-8B751A388A7C

Q28282376-1C05C9B7-19FA-4727-9219-9FB825F41EDE

Q28282376-1FC4E8FF-1A00-4F9D-8DF6-07096BD3C161

P304

Q28282376-03ED7BE3-4FE2-494F-A5DC-6A1A9E4FE00D

P31

Q28282376-04F9E9AE-E1F4-44AF-A1E8-A3CB4F0FE19B

P356

Q28282376-27A5DF77-2190-4BA6-ACFA-F33CCA278B33

P407

Q28282376-D953CAFA-F425-48A8-B9CE-B56A0D78456D

P433

Q28282376-F2298F8C-14FC-42E2-9F0E-7B0DF63702DB

P478

Q28282376-DFC10951-8754-4A23-8B27-C5BACFD17999

P577

Q28282376-B0E60A57-1704-430C-B0AC-C85E7EA8CCDB

P698

Q28282376-D52D818C-6094-4D4D-BDEF-9D301C89E1B0

P921

Q28282376-06980EF4-E602-4C5F-ADFC-41DE61938E78

P932

Q28282376-1650DC87-042E-42A6-8AAC-E1EC70A90E45

P356

J.IDC.2010.01.001

P1433

Infectious Disease Clinics of North America

P1476

Antiviral drug resistance: mechanisms and clinical implications

@en

P2093

Lynne Strasfeld

http://www.w3.org/2001/XMLSchema#string

Sunwen Chou

http://www.w3.org/2001/XMLSchema#string

P2860

Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients

Phenotypic and genetic characterization of thymidine kinase from clinical strains of varicella-zoster virus resistant to acyclovir

A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products.

In vitro susceptibility of varicella-zoster virus to acyclovir

Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients

Valganciclovir for cytomegalovirus prevention in solid organ transplant patients: an evidence-based reassessment of safety and efficacy

Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine.

Two-year assessment of entecavir resistance in Lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions present

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy.

How evolution of mutations conferring drug resistance affects viral dynamics and clinical outcomes of cytomegalovirus-infected hematopoietic cell transplant recipients.

P304

413-37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IDC.2010.01.001

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20466277

http://www.w3.org/2001/XMLSchema#string

P921

infectious disease

P932

2871161

http://www.w3.org/2001/XMLSchema#string